DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Seltorexant
Seltorexant
Clinical Pharmacology of Daridorexant, a Novel Dual Orexin Receptor Antagonist
Orexins, Sleep, and Blood Pressure
Royalty Pharma Minerva Press Release January 19 2021
Tackling Insomnia As Part of the Complete Approach to Mental Healthcare
ACNP 59Th Annual Meeting: Panels, Mini-Panels and Study Groups
ACNP 59Th Annual Meeting: Poster Session III
Structure-Based Development of a Subtype-Selective Orexin 1 Receptor Antagonist
A New Dual Orexin Receptor Antagonist for the Treatment of Insomnia
Reaching out for More
1500 T 7 Minerva Neurosciencs.Pptx
Current and Emerging Therapies for Insomnia Mei T
The Use of Physiology-Based PK and PD Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
Karl Doghramji, MD
Judy Robertson Speaking Notes
Bioactive Compound Library Plus (96-Well)
Seltorexant (MIN-202)
Product Data Sheet
Duarte Nuno Sampaio Loio
Top View
Rôle Antitumoral De L'orexine a Et Des Ligands Biaisés Dans Les Cancers Digestifs
ACNP 58Th Annual Meeting: Poster Session I
The Use of Physiology-Based PK and PD Modeling in the Discovery of the Dual
Orexin 2 Receptor Antagonists from Prefrontal Cortical Circuitry to Rodent Behavioral Screens Gerard J
Orexin Receptor (OX Receptor) Hypocretin Receptor; HCRT Receptor
The Selective Orexin-2 Antagonist Seltorexant (JNJ-42847922/MIN
Orexins, Sleep, and Blood Pressure
Endocrinology Compound Library (96-Well)
Structure-Based Development of a Subtype-Selective Orexin 1 Receptor Antagonist
Minerva Neurosciences, Inc
Preclinical in Vivo Characterization of Lemborexant (E2006)